Cases selected for the AskAnzal weekly PMCPA insight newsletter
Baxter UK was ruled in breach of Clause 9.1 after exhibiting at a Northern Ireland urology meeting held…
A hospital doctor said GSKβs βdo more, feel better, live longerβ strapline on a BTS stand invitation implied…
Anonymous prescriber alleged GSK hid asthma pneumonia risk in Relvar promotion and cherry-picked COPD comparisons. PMCPA Panel found…
Janssen admitted a Crohnβs awareness campaign sent to UK gastroenterologists promoted ustekinumab for an unlicensed indication and was…
PV consultant alleged off-label exacerbation-risk promotion for Ultibro. Panel found breaches for a FLAME βbusiness cardβ and unclear…
Lilly challenged a Levemir advertorial in Pulse. PMCPA found the βWeight advantages with Levemirβ section misleading/ambiguous and inconsistent…
Servier repβs proactive call rate exceeded Code limits and biscuits/snacks were used to gain access. Panel found breaches…
A pharmacist alleged Servier reused a Coversyl ad previously ruled misleading. The Panel found the ad had been…
A medical representative alleged AstraZeneca meetings were visible to the public and that surgery meetings were fund-raising with…
Ferring agreed in inter-company dialogue to withdraw a Cortiment leavepiece but it was still used at a conference…
One real case. One key lesson. Every week β free.